Skip to content

13F-HR filed by Chicago Capital Management, LLC

Chicago Capital Management, LLC filed this 13F-HR for the quarter ended 2026-06-30, filed 2026-07-22, with 27 holding rows worth $112,300,553.

Accession
0001062993-26-003767
Filed
2026-07-22
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q2 2026

A combination report, 27 entries on the cover page, a total value of $112,300,553 stated on the cover page (in dollars after the unit check, H1), rows summing to $112,300,553 with VALUE read as dollars as filed, 13F file number 028-16889. The quarter's positions are built on this report. The resolved quarter.

Other managers

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
NUVALENT INC COM670703107Stock115,500$11,053,250dollars as filed
APOGEE THERAPEUTICS INC COM03770N101Stock97,100$9,807,420dollars as filed
CHART INDS INC16115Q308COM53,000$8,357,600dollars as filed
BANDWIDTH INC05988JAD5NOTE 0.500% 4/08,153$7,623,055dollars as filedprincipal
TAYLOR MORRISON HOME CORP COM87724P106Stock133,000$7,174,000dollars as filed
SABRE GLBL INC78573NAK8NOTE 7.320% 8/06,904$7,123,202dollars as filedprincipal
RAPID7 INC753422AF1NOTE 0.250% 3/16,520$6,312,899dollars as filedprincipal
MGP INGREDIENTS INC NEW55303JAB2NOTE 1.875%11/16,068$5,930,838dollars as filedprincipal
VERITONE INC92347MAB6NOTE 1.750%11/15,500$5,388,549dollars as filedprincipal
AMPHASTAR PHARMACEUTICALS IN03209RAB9NOTE 2.000% 3/15,440$4,975,636dollars as filedprincipal
THE REALREAL INC88339PAD3CNV5,307$4,784,437dollars as filedprincipal
FIVE9 INC338307AF8CNV5,000$4,477,222dollars as filedprincipal
SHAKE SHACK INC819047AB7NOTE 3/04,189$3,969,078dollars as filedprincipal
ETSY INC29786AAN6NOTE 0.250% 6/14,292$3,928,944dollars as filedprincipal
HEWLETT PACKARD ENTERPRISE C42824C208CMN32,900$3,805,214dollars as filed
SAREPTA THERAPEUTICS INC803607AD2NOTE 1.250% 9/13,170$2,997,807dollars as filedprincipal
CATALYST PHARMACEUTICALS INC14888U101COM122,650$2,933,048dollars as filed
ASTRONOVA INC04638F108COM131,100$2,849,135dollars as filed
ESPERION THERAPEUTICS INC NEW COM29664W105Stock830,935$2,607,000dollars as filed
BIO-TECHNE CORP09073M104COM37,509$2,017,481dollars as filed
XEROX HOLDINGS CORP98421MAE6NOTE 3.750% 3/14,000$1,444,167dollars as filedprincipal
PAR TECHNOLOGY CORP698884AE3NOTE 1.500%10/11,127$1,072,971dollars as filedprincipal
TRUBRIDGE INC205306103COM34,663$685,785dollars as filed
STELLAR BANCORP INC858927106COM11,559$342,427dollars as filed
ELECTRONIC ARTS INC COM285512109Stock2,000$309,200dollars as filed
NSTS BANCORP INC6293JP109COM29,020$303,793dollars as filed
XEROX HOLDINGS CORP98421M114*W EXP 02/11/20295,980$26,395dollars as filed

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001062993-26-003767this filing2026-07-22acceptance time not in the bulk data set